A well-established diabetes drug alleviated brain inflammation in a female mouse model of multiple sclerosis, suggesting the ...

GSK plc announced plans to invest $30 billion in U.S. research and manufacturing over the next five years and entered a $500 ...

GSK’s depemokimab shows strong potential for United States Food and Drug Administration approval in asthma and chronic ...

The global Muscle Relaxant Drugs Market is poised for significant growth over the next decade, underscoring expanding ...

Updates in relapsing-remitting MS from ECTRIMS 2025 examine lifestyle interventions, anti-CD20 therapies, efficacy of fenebrutinib, and bone marrow transplantation as an effective long-term treatment.

Additional early research suggested that combining metformin and clemastine may promote remyelination, offering hope for ...

Now, by analyzing thousands of proteins found in the blood, scientists at UC San Francisco have created the clearest picture ...

Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells ...

Sanofi (SNY) stock and Insmed (INSM) stock are in focus as new treatments from the companies win backing from an expert panel ...

About 100,000 of the estimated million people in the United States with multiple sclerosis (MS) have a progressive form of ...

Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose Compared to ...

The 975 guests at the 39th Carousel Ball knew that the legendary singer-songwriter Neil Diamond would be at this fundraiser for the Barbara Davis Center for Diabetes to accept the Inspirational ...